Video

Dr. Berg highlights key ongoing trials in urothelial cancer

Stephanie Berg, DO, highlights key ongoing trials in advanced/metastatic urothelial cancer, including EV-302 (NCT04223856), NILE (NCT03682068) CheckMate-901 (NCT03036098), and MAIN-CAV (NCT05092958).Berg is an instructor of medicine, Harvard Medical School, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute.

Related Videos
Interpreting ART toxicity and tolerability for bladder cancer, with Vedang Murthy, MD
Trinity Bivalacqua, MD, PhD, and Mark Tyson, MD, MPH, experts on bladder cancer
Trinity Bivalacqua, MD, PhD, and Mark Tyson, MD, MPH, experts on bladder cancer
Related Content
© 2024 MJH Life Sciences

All rights reserved.